Actively Recruiting
Study of Stereotactic Radiation Therapy Combined With Anlotinib for Treating Brain Metastases in Non-Small Cell Lung Cancer Patients
Led by The First People's Hospital of Lianyungang · Updated on 2024-06-26
46
Participants Needed
1
Research Sites
8 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the effectiveness and safety of combining stereotactic radiation therapy SRT with the drug anlotinib to treat patients who have a limited number of brain metastases originating from non-small cell lung cancer NSCLC. Anlotinib is an oral medication that targets multiple pathways involved in tumor growth, and SRT delivers focused radiation to brain lesions, aiming to preserve brain function better than whole brain radiation. This study is a prospective, exploratory clinical trial sponsored by The First Peoples Hospital of Lianyungang. Participants receive oral anlotinib at a dose of 12 mg for 14 days every 3 weeks alongside stereotactic radiation therapy targeting up to five brain metastases. The trial focuses on patients with confirmed NSCLC and brain metastases who are physically able to undergo SRT. This single-arm study does not include a comparison group and follows patients during and after treatment to assess response and safety. During the study, participants will be monitored for tumor response in the brain using imaging and clinical assessments over 20 months. Researchers will measure intracerebral progression-free survival iPFS, response rates, and other survival outcomes, as well as track safety and adverse effects. Patients will be evaluated regularly to assess disease control and overall health while continuing treatment and follow-up visits as planned until the study ends or disease progression occurs.
CONDITIONS
Brief Title
SRT Combined With Anlotinib for the Treatment of Brain Metastases From Non-small Cell Lung Cancer
Research Team
X
Xiaodong Jiang, Doc
X
Xiaodong Jiang, Doc
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here